nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—RRM1—Fulvestrant—Estradiol—osteoporosis	0.019	1	CbGdCrCtD
Hydroxyurea—RRM1—Nucleotide metabolism—PNP—osteoporosis	0.00905	0.0865	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide metabolism—ATIC—osteoporosis	0.00905	0.0865	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—PNP—osteoporosis	0.00745	0.0713	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—ATIC—osteoporosis	0.00745	0.0713	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00471	0.045	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00388	0.0371	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide metabolism—GPX1—osteoporosis	0.00256	0.0245	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—PSMA2—osteoporosis	0.00245	0.0234	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—PSMA5—osteoporosis	0.00245	0.0234	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00238	0.0228	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—GPX1—osteoporosis	0.00211	0.0202	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.00206	0.0197	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.00206	0.0197	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.00169	0.0162	CbGpPWpGaD
Hydroxyurea—Somnolence—Estropipate—osteoporosis	0.00148	0.00169	CcSEcCtD
Hydroxyurea—Dyspepsia—Estropipate—osteoporosis	0.00147	0.00168	CcSEcCtD
Hydroxyurea—Angiopathy—Zoledronate—osteoporosis	0.00146	0.00167	CcSEcCtD
Hydroxyurea—Dyspepsia—Alendronate—osteoporosis	0.00145	0.00165	CcSEcCtD
Hydroxyurea—Chills—Zoledronate—osteoporosis	0.00145	0.00165	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Estropipate—osteoporosis	0.00144	0.00164	CcSEcCtD
Hydroxyurea—Fatigue—Estropipate—osteoporosis	0.00144	0.00164	CcSEcCtD
Hydroxyurea—Constipation—Estropipate—osteoporosis	0.00143	0.00163	CcSEcCtD
Hydroxyurea—Pain—Estropipate—osteoporosis	0.00143	0.00163	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Pamidronate—osteoporosis	0.00143	0.00163	CcSEcCtD
Hydroxyurea—Alopecia—Zoledronate—osteoporosis	0.00142	0.00162	CcSEcCtD
Hydroxyurea—Dyspepsia—Raloxifene—osteoporosis	0.00142	0.00162	CcSEcCtD
Hydroxyurea—Hypersensitivity—Etidronic acid—osteoporosis	0.00142	0.00162	CcSEcCtD
Hydroxyurea—Anaemia—Pamidronate—osteoporosis	0.00142	0.00162	CcSEcCtD
Hydroxyurea—Weight increased—Estradiol—osteoporosis	0.00141	0.00161	CcSEcCtD
Hydroxyurea—Dyspepsia—Ibandronate—osteoporosis	0.00141	0.00161	CcSEcCtD
Hydroxyurea—Angiopathy—Conjugated Estrogens—osteoporosis	0.00141	0.00161	CcSEcCtD
Hydroxyurea—Constipation—Alendronate—osteoporosis	0.00141	0.0016	CcSEcCtD
Hydroxyurea—Pain—Alendronate—osteoporosis	0.00141	0.0016	CcSEcCtD
Hydroxyurea—Erythema—Zoledronate—osteoporosis	0.0014	0.0016	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.0014	0.0016	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Raloxifene—osteoporosis	0.0014	0.00159	CcSEcCtD
Hydroxyurea—Discomfort—Ethinyl Estradiol—osteoporosis	0.00139	0.00159	CcSEcCtD
Hydroxyurea—Somnolence—Calcitriol—osteoporosis	0.00139	0.00159	CcSEcCtD
Hydroxyurea—Decreased appetite—Ibandronate—osteoporosis	0.00139	0.00159	CcSEcCtD
Hydroxyurea—Malaise—Pamidronate—osteoporosis	0.00139	0.00158	CcSEcCtD
Hydroxyurea—Infestation NOS—Estradiol—osteoporosis	0.00138	0.00158	CcSEcCtD
Hydroxyurea—Infestation—Estradiol—osteoporosis	0.00138	0.00158	CcSEcCtD
Hydroxyurea—Pain—Raloxifene—osteoporosis	0.00138	0.00158	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00138	0.00158	CcSEcCtD
Hydroxyurea—Fatigue—Ibandronate—osteoporosis	0.00138	0.00157	CcSEcCtD
Hydroxyurea—Leukopenia—Pamidronate—osteoporosis	0.00137	0.00157	CcSEcCtD
Hydroxyurea—Alopecia—Conjugated Estrogens—osteoporosis	0.00137	0.00156	CcSEcCtD
Hydroxyurea—Constipation—Ibandronate—osteoporosis	0.00137	0.00156	CcSEcCtD
Hydroxyurea—Pain—Ibandronate—osteoporosis	0.00137	0.00156	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00137	0.00156	CcSEcCtD
Hydroxyurea—Decreased appetite—Calcitriol—osteoporosis	0.00136	0.00155	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Estradiol—osteoporosis	0.00136	0.00155	CcSEcCtD
Hydroxyurea—Feeling abnormal—Alendronate—osteoporosis	0.00135	0.00155	CcSEcCtD
Hydroxyurea—Oedema—Ethinyl Estradiol—osteoporosis	0.00135	0.00154	CcSEcCtD
Hydroxyurea—Erythema—Conjugated Estrogens—osteoporosis	0.00135	0.00154	CcSEcCtD
Hydroxyurea—Infection—Ethinyl Estradiol—osteoporosis	0.00134	0.00153	CcSEcCtD
Hydroxyurea—Pain—Calcitriol—osteoporosis	0.00134	0.00153	CcSEcCtD
Hydroxyurea—Constipation—Calcitriol—osteoporosis	0.00134	0.00153	CcSEcCtD
Hydroxyurea—Convulsion—Pamidronate—osteoporosis	0.00133	0.00152	CcSEcCtD
Hydroxyurea—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00133	0.00151	CcSEcCtD
Hydroxyurea—Diarrhoea—Etidronic acid—osteoporosis	0.00132	0.00151	CcSEcCtD
Hydroxyurea—Body temperature increased—Estropipate—osteoporosis	0.00132	0.0015	CcSEcCtD
Hydroxyurea—Feeling abnormal—Ibandronate—osteoporosis	0.00132	0.0015	CcSEcCtD
Hydroxyurea—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00131	0.0015	CcSEcCtD
Hydroxyurea—Infection—Risedronate—osteoporosis	0.00131	0.00149	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Estradiol—osteoporosis	0.00131	0.00149	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Zoledronate—osteoporosis	0.0013	0.00149	CcSEcCtD
Hydroxyurea—Body temperature increased—Alendronate—osteoporosis	0.0013	0.00148	CcSEcCtD
Hydroxyurea—Anaemia—Zoledronate—osteoporosis	0.0013	0.00148	CcSEcCtD
Hydroxyurea—Nervous system disorder—Risedronate—osteoporosis	0.00129	0.00148	CcSEcCtD
Hydroxyurea—Discomfort—Pamidronate—osteoporosis	0.00129	0.00147	CcSEcCtD
Hydroxyurea—Skin disorder—Risedronate—osteoporosis	0.00128	0.00146	CcSEcCtD
Hydroxyurea—Body temperature increased—Raloxifene—osteoporosis	0.00128	0.00146	CcSEcCtD
Hydroxyurea—Malaise—Zoledronate—osteoporosis	0.00127	0.00144	CcSEcCtD
Hydroxyurea—Body temperature increased—Ibandronate—osteoporosis	0.00126	0.00144	CcSEcCtD
Hydroxyurea—Leukopenia—Zoledronate—osteoporosis	0.00126	0.00143	CcSEcCtD
Hydroxyurea—Oedema—Pamidronate—osteoporosis	0.00125	0.00143	CcSEcCtD
Hydroxyurea—Haemoglobin—Estradiol—osteoporosis	0.00125	0.00142	CcSEcCtD
Hydroxyurea—Infection—Pamidronate—osteoporosis	0.00125	0.00142	CcSEcCtD
Hydroxyurea—Haemorrhage—Estradiol—osteoporosis	0.00124	0.00142	CcSEcCtD
Hydroxyurea—Body temperature increased—Calcitriol—osteoporosis	0.00124	0.00141	CcSEcCtD
Hydroxyurea—Hypersensitivity—Estropipate—osteoporosis	0.00123	0.0014	CcSEcCtD
Hydroxyurea—Nervous system disorder—Pamidronate—osteoporosis	0.00123	0.0014	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Pamidronate—osteoporosis	0.00123	0.0014	CcSEcCtD
Hydroxyurea—Vomiting—Etidronic acid—osteoporosis	0.00123	0.0014	CcSEcCtD
Hydroxyurea—Rash—Etidronic acid—osteoporosis	0.00122	0.00139	CcSEcCtD
Hydroxyurea—Convulsion—Zoledronate—osteoporosis	0.00122	0.00139	CcSEcCtD
Hydroxyurea—Dermatitis—Etidronic acid—osteoporosis	0.00121	0.00139	CcSEcCtD
Hydroxyurea—Hypersensitivity—Alendronate—osteoporosis	0.00121	0.00138	CcSEcCtD
Hydroxyurea—Headache—Etidronic acid—osteoporosis	0.00121	0.00138	CcSEcCtD
Hydroxyurea—Asthenia—Estropipate—osteoporosis	0.0012	0.00137	CcSEcCtD
Hydroxyurea—Anorexia—Pamidronate—osteoporosis	0.00119	0.00136	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00119	0.00135	CcSEcCtD
Hydroxyurea—Discomfort—Zoledronate—osteoporosis	0.00118	0.00135	CcSEcCtD
Hydroxyurea—Asthenia—Alendronate—osteoporosis	0.00118	0.00135	CcSEcCtD
Hydroxyurea—Hypersensitivity—Ibandronate—osteoporosis	0.00118	0.00135	CcSEcCtD
Hydroxyurea—Dyspnoea—Risedronate—osteoporosis	0.00118	0.00134	CcSEcCtD
Hydroxyurea—Convulsion—Conjugated Estrogens—osteoporosis	0.00117	0.00134	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00117	0.00133	CcSEcCtD
Hydroxyurea—Fatigue—Ethinyl Estradiol—osteoporosis	0.00117	0.00133	CcSEcCtD
Hydroxyurea—Dyspepsia—Risedronate—osteoporosis	0.00116	0.00132	CcSEcCtD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00116	0.0111	CbGpPWpGaD
Hydroxyurea—Constipation—Ethinyl Estradiol—osteoporosis	0.00116	0.00132	CcSEcCtD
Hydroxyurea—Hypersensitivity—Calcitriol—osteoporosis	0.00115	0.00132	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—MYC—osteoporosis	0.00115	0.011	CbGpPWpGaD
Hydroxyurea—Asthenia—Ibandronate—osteoporosis	0.00115	0.00131	CcSEcCtD
Hydroxyurea—Nausea—Etidronic acid—osteoporosis	0.00115	0.00131	CcSEcCtD
Hydroxyurea—Oedema—Zoledronate—osteoporosis	0.00114	0.00131	CcSEcCtD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00114	0.0109	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00114	0.0013	CcSEcCtD
Hydroxyurea—Diarrhoea—Estropipate—osteoporosis	0.00114	0.0013	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Risedronate—osteoporosis	0.00114	0.0013	CcSEcCtD
Hydroxyurea—Infection—Zoledronate—osteoporosis	0.00114	0.0013	CcSEcCtD
Hydroxyurea—Fatigue—Risedronate—osteoporosis	0.00114	0.0013	CcSEcCtD
Hydroxyurea—Constipation—Risedronate—osteoporosis	0.00113	0.00129	CcSEcCtD
Hydroxyurea—Pain—Risedronate—osteoporosis	0.00113	0.00129	CcSEcCtD
Hydroxyurea—Angiopathy—Estradiol—osteoporosis	0.00113	0.00129	CcSEcCtD
Hydroxyurea—Diarrhoea—Alendronate—osteoporosis	0.00112	0.00128	CcSEcCtD
Hydroxyurea—Asthenia—Calcitriol—osteoporosis	0.00112	0.00128	CcSEcCtD
Hydroxyurea—Nervous system disorder—Zoledronate—osteoporosis	0.00112	0.00128	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Zoledronate—osteoporosis	0.00112	0.00128	CcSEcCtD
Hydroxyurea—Dyspnoea—Pamidronate—osteoporosis	0.00112	0.00128	CcSEcCtD
Hydroxyurea—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00111	0.00127	CcSEcCtD
Hydroxyurea—Chills—Estradiol—osteoporosis	0.00111	0.00127	CcSEcCtD
Hydroxyurea—Somnolence—Pamidronate—osteoporosis	0.00111	0.00127	CcSEcCtD
Hydroxyurea—Skin disorder—Zoledronate—osteoporosis	0.00111	0.00127	CcSEcCtD
Hydroxyurea—Diarrhoea—Raloxifene—osteoporosis	0.00111	0.00126	CcSEcCtD
Hydroxyurea—Dyspepsia—Pamidronate—osteoporosis	0.0011	0.00126	CcSEcCtD
Hydroxyurea—Dizziness—Estropipate—osteoporosis	0.0011	0.00126	CcSEcCtD
Hydroxyurea—Oedema—Conjugated Estrogens—osteoporosis	0.0011	0.00126	CcSEcCtD
Hydroxyurea—Alopecia—Estradiol—osteoporosis	0.0011	0.00125	CcSEcCtD
Hydroxyurea—Infection—Conjugated Estrogens—osteoporosis	0.0011	0.00125	CcSEcCtD
Hydroxyurea—Diarrhoea—Ibandronate—osteoporosis	0.00109	0.00125	CcSEcCtD
Hydroxyurea—Anorexia—Zoledronate—osteoporosis	0.00109	0.00125	CcSEcCtD
Hydroxyurea—Decreased appetite—Pamidronate—osteoporosis	0.00109	0.00124	CcSEcCtD
Hydroxyurea—Dizziness—Alendronate—osteoporosis	0.00109	0.00124	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00108	0.00123	CcSEcCtD
Hydroxyurea—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00108	0.00123	CcSEcCtD
Hydroxyurea—Erythema—Estradiol—osteoporosis	0.00108	0.00123	CcSEcCtD
Hydroxyurea—Fatigue—Pamidronate—osteoporosis	0.00108	0.00123	CcSEcCtD
Hydroxyurea—Constipation—Pamidronate—osteoporosis	0.00107	0.00122	CcSEcCtD
Hydroxyurea—Pain—Pamidronate—osteoporosis	0.00107	0.00122	CcSEcCtD
Hydroxyurea—Diarrhoea—Calcitriol—osteoporosis	0.00107	0.00122	CcSEcCtD
Hydroxyurea—Skin disorder—Conjugated Estrogens—osteoporosis	0.00107	0.00122	CcSEcCtD
Hydroxyurea—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00107	0.00122	CcSEcCtD
Hydroxyurea—Dizziness—Raloxifene—osteoporosis	0.00107	0.00122	CcSEcCtD
Hydroxyurea—Vomiting—Estropipate—osteoporosis	0.00106	0.00121	CcSEcCtD
Hydroxyurea—Dizziness—Ibandronate—osteoporosis	0.00106	0.00121	CcSEcCtD
Hydroxyurea—Rash—Estropipate—osteoporosis	0.00105	0.0012	CcSEcCtD
Hydroxyurea—Dermatitis—Estropipate—osteoporosis	0.00105	0.0012	CcSEcCtD
Hydroxyurea—Anorexia—Conjugated Estrogens—osteoporosis	0.00105	0.0012	CcSEcCtD
Hydroxyurea—Headache—Estropipate—osteoporosis	0.00105	0.00119	CcSEcCtD
Hydroxyurea—Vomiting—Alendronate—osteoporosis	0.00104	0.00119	CcSEcCtD
Hydroxyurea—Body temperature increased—Risedronate—osteoporosis	0.00104	0.00119	CcSEcCtD
Hydroxyurea—Rash—Alendronate—osteoporosis	0.00104	0.00118	CcSEcCtD
Hydroxyurea—Dermatitis—Alendronate—osteoporosis	0.00104	0.00118	CcSEcCtD
Hydroxyurea—Feeling abnormal—Pamidronate—osteoporosis	0.00103	0.00118	CcSEcCtD
Hydroxyurea—Headache—Alendronate—osteoporosis	0.00103	0.00117	CcSEcCtD
Hydroxyurea—Vomiting—Raloxifene—osteoporosis	0.00103	0.00117	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.00103	0.00982	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Zoledronate—osteoporosis	0.00102	0.00116	CcSEcCtD
Hydroxyurea—Rash—Raloxifene—osteoporosis	0.00102	0.00116	CcSEcCtD
Hydroxyurea—Dermatitis—Raloxifene—osteoporosis	0.00102	0.00116	CcSEcCtD
Hydroxyurea—Somnolence—Zoledronate—osteoporosis	0.00102	0.00116	CcSEcCtD
Hydroxyurea—Vomiting—Ibandronate—osteoporosis	0.00102	0.00116	CcSEcCtD
Hydroxyurea—Headache—Raloxifene—osteoporosis	0.00101	0.00116	CcSEcCtD
Hydroxyurea—Rash—Ibandronate—osteoporosis	0.00101	0.00115	CcSEcCtD
Hydroxyurea—Dermatitis—Ibandronate—osteoporosis	0.00101	0.00115	CcSEcCtD
Hydroxyurea—Dyspepsia—Zoledronate—osteoporosis	0.00101	0.00115	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Estradiol—osteoporosis	0.001	0.00114	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.001	0.00959	CbGpPWpGaD
Hydroxyurea—Headache—Ibandronate—osteoporosis	0.001	0.00114	CcSEcCtD
Hydroxyurea—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000996	0.00114	CcSEcCtD
Hydroxyurea—Vomiting—Calcitriol—osteoporosis	0.000996	0.00114	CcSEcCtD
Hydroxyurea—Decreased appetite—Zoledronate—osteoporosis	0.000995	0.00114	CcSEcCtD
Hydroxyurea—Nausea—Estropipate—osteoporosis	0.000991	0.00113	CcSEcCtD
Hydroxyurea—Body temperature increased—Pamidronate—osteoporosis	0.000991	0.00113	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000988	0.00113	CcSEcCtD
Hydroxyurea—Rash—Calcitriol—osteoporosis	0.000988	0.00113	CcSEcCtD
Hydroxyurea—Fatigue—Zoledronate—osteoporosis	0.000987	0.00113	CcSEcCtD
Hydroxyurea—Dermatitis—Calcitriol—osteoporosis	0.000987	0.00113	CcSEcCtD
Hydroxyurea—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000983	0.00112	CcSEcCtD
Hydroxyurea—Headache—Calcitriol—osteoporosis	0.000981	0.00112	CcSEcCtD
Hydroxyurea—Somnolence—Conjugated Estrogens—osteoporosis	0.00098	0.00112	CcSEcCtD
Hydroxyurea—Pain—Zoledronate—osteoporosis	0.000979	0.00112	CcSEcCtD
Hydroxyurea—Constipation—Zoledronate—osteoporosis	0.000979	0.00112	CcSEcCtD
Hydroxyurea—Nausea—Alendronate—osteoporosis	0.000976	0.00111	CcSEcCtD
Hydroxyurea—Malaise—Estradiol—osteoporosis	0.000975	0.00111	CcSEcCtD
Hydroxyurea—Hypersensitivity—Risedronate—osteoporosis	0.000971	0.00111	CcSEcCtD
Hydroxyurea—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00097	0.00111	CcSEcCtD
Hydroxyurea—Asthenia—Ethinyl Estradiol—osteoporosis	0.00097	0.00111	CcSEcCtD
Hydroxyurea—Nausea—Raloxifene—osteoporosis	0.00096	0.0011	CcSEcCtD
Hydroxyurea—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000958	0.00109	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000952	0.00109	CcSEcCtD
Hydroxyurea—Fatigue—Conjugated Estrogens—osteoporosis	0.000951	0.00108	CcSEcCtD
Hydroxyurea—Nausea—Ibandronate—osteoporosis	0.00095	0.00108	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—MYC—osteoporosis	0.00095	0.00908	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PKM—osteoporosis	0.000948	0.00907	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—FDPS—osteoporosis	0.000948	0.00907	CbGpPWpGaD
Hydroxyurea—Asthenia—Risedronate—osteoporosis	0.000946	0.00108	CcSEcCtD
Hydroxyurea—Feeling abnormal—Zoledronate—osteoporosis	0.000944	0.00108	CcSEcCtD
Hydroxyurea—Pain—Conjugated Estrogens—osteoporosis	0.000943	0.00108	CcSEcCtD
Hydroxyurea—Constipation—Conjugated Estrogens—osteoporosis	0.000943	0.00108	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00094	0.00899	CbGpPWpGaD
Hydroxyurea—Nausea—Calcitriol—osteoporosis	0.00093	0.00106	CcSEcCtD
Hydroxyurea—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000925	0.00106	CcSEcCtD
Hydroxyurea—Hypersensitivity—Pamidronate—osteoporosis	0.000924	0.00105	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000914	0.00104	CcSEcCtD
Hydroxyurea—Discomfort—Estradiol—osteoporosis	0.000909	0.00104	CcSEcCtD
Hydroxyurea—Body temperature increased—Zoledronate—osteoporosis	0.000905	0.00103	CcSEcCtD
Hydroxyurea—Diarrhoea—Risedronate—osteoporosis	0.000902	0.00103	CcSEcCtD
Hydroxyurea—Asthenia—Pamidronate—osteoporosis	0.000899	0.00103	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GPD2—osteoporosis	0.000899	0.00859	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PGLS—osteoporosis	0.000899	0.00859	CbGpPWpGaD
Hydroxyurea—Dizziness—Ethinyl Estradiol—osteoporosis	0.000894	0.00102	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000889	0.0085	CbGpPWpGaD
Hydroxyurea—Oedema—Estradiol—osteoporosis	0.000882	0.00101	CcSEcCtD
Hydroxyurea—Infection—Estradiol—osteoporosis	0.000877	0.001	CcSEcCtD
Hydroxyurea—Dizziness—Risedronate—osteoporosis	0.000872	0.000995	CcSEcCtD
Hydroxyurea—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000872	0.000994	CcSEcCtD
Hydroxyurea—Nervous system disorder—Estradiol—osteoporosis	0.000865	0.000987	CcSEcCtD
Hydroxyurea—Vomiting—Ethinyl Estradiol—osteoporosis	0.00086	0.000981	CcSEcCtD
Hydroxyurea—Diarrhoea—Pamidronate—osteoporosis	0.000858	0.000979	CcSEcCtD
Hydroxyurea—Skin disorder—Estradiol—osteoporosis	0.000857	0.000978	CcSEcCtD
Hydroxyurea—Rash—Ethinyl Estradiol—osteoporosis	0.000853	0.000973	CcSEcCtD
Hydroxyurea—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000852	0.000972	CcSEcCtD
Hydroxyurea—Headache—Ethinyl Estradiol—osteoporosis	0.000847	0.000967	CcSEcCtD
Hydroxyurea—Hypersensitivity—Zoledronate—osteoporosis	0.000844	0.000963	CcSEcCtD
Hydroxyurea—Vomiting—Risedronate—osteoporosis	0.000838	0.000957	CcSEcCtD
Hydroxyurea—Rash—Risedronate—osteoporosis	0.000831	0.000949	CcSEcCtD
Hydroxyurea—Dermatitis—Risedronate—osteoporosis	0.000831	0.000948	CcSEcCtD
Hydroxyurea—Dizziness—Pamidronate—osteoporosis	0.000829	0.000946	CcSEcCtD
Hydroxyurea—Headache—Risedronate—osteoporosis	0.000826	0.000943	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000825	0.00789	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PNP—osteoporosis	0.000822	0.00786	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ATIC—osteoporosis	0.000822	0.00786	CbGpPWpGaD
Hydroxyurea—Asthenia—Zoledronate—osteoporosis	0.000821	0.000937	CcSEcCtD
Hydroxyurea—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000812	0.000927	CcSEcCtD
Hydroxyurea—Nausea—Ethinyl Estradiol—osteoporosis	0.000803	0.000917	CcSEcCtD
Hydroxyurea—Vomiting—Pamidronate—osteoporosis	0.000797	0.000909	CcSEcCtD
Hydroxyurea—Asthenia—Conjugated Estrogens—osteoporosis	0.000791	0.000903	CcSEcCtD
Hydroxyurea—Rash—Pamidronate—osteoporosis	0.00079	0.000902	CcSEcCtD
Hydroxyurea—Dermatitis—Pamidronate—osteoporosis	0.00079	0.000901	CcSEcCtD
Hydroxyurea—Dyspnoea—Estradiol—osteoporosis	0.000787	0.000898	CcSEcCtD
Hydroxyurea—Headache—Pamidronate—osteoporosis	0.000785	0.000896	CcSEcCtD
Hydroxyurea—Somnolence—Estradiol—osteoporosis	0.000784	0.000895	CcSEcCtD
Hydroxyurea—Diarrhoea—Zoledronate—osteoporosis	0.000783	0.000894	CcSEcCtD
Hydroxyurea—Nausea—Risedronate—osteoporosis	0.000783	0.000894	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—FDPS—osteoporosis	0.000781	0.00747	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PKM—osteoporosis	0.000781	0.00747	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Estradiol—osteoporosis	0.000777	0.000886	CcSEcCtD
Hydroxyurea—Decreased appetite—Estradiol—osteoporosis	0.000767	0.000875	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Estradiol—osteoporosis	0.000762	0.000869	CcSEcCtD
Hydroxyurea—Fatigue—Estradiol—osteoporosis	0.000761	0.000868	CcSEcCtD
Hydroxyurea—Dizziness—Zoledronate—osteoporosis	0.000757	0.000864	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000756	0.00723	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000756	0.00723	CbGpPWpGaD
Hydroxyurea—Constipation—Estradiol—osteoporosis	0.000755	0.000861	CcSEcCtD
Hydroxyurea—Pain—Estradiol—osteoporosis	0.000755	0.000861	CcSEcCtD
Hydroxyurea—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000754	0.000861	CcSEcCtD
Hydroxyurea—Nausea—Pamidronate—osteoporosis	0.000745	0.00085	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PGLS—osteoporosis	0.00074	0.00708	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GPD2—osteoporosis	0.00074	0.00708	CbGpPWpGaD
Hydroxyurea—Dizziness—Conjugated Estrogens—osteoporosis	0.000729	0.000832	CcSEcCtD
Hydroxyurea—Vomiting—Zoledronate—osteoporosis	0.000728	0.000831	CcSEcCtD
Hydroxyurea—Feeling abnormal—Estradiol—osteoporosis	0.000727	0.00083	CcSEcCtD
Hydroxyurea—Rash—Zoledronate—osteoporosis	0.000722	0.000824	CcSEcCtD
Hydroxyurea—Dermatitis—Zoledronate—osteoporosis	0.000721	0.000823	CcSEcCtD
Hydroxyurea—Headache—Zoledronate—osteoporosis	0.000717	0.000818	CcSEcCtD
Hydroxyurea—Vomiting—Conjugated Estrogens—osteoporosis	0.000701	0.0008	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—OXCT1—osteoporosis	0.000699	0.00668	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CA2—osteoporosis	0.000699	0.00668	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Estradiol—osteoporosis	0.000698	0.000796	CcSEcCtD
Hydroxyurea—Rash—Conjugated Estrogens—osteoporosis	0.000695	0.000793	CcSEcCtD
Hydroxyurea—Dermatitis—Conjugated Estrogens—osteoporosis	0.000694	0.000792	CcSEcCtD
Hydroxyurea—Headache—Conjugated Estrogens—osteoporosis	0.000691	0.000788	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—MYC—osteoporosis	0.000689	0.00659	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—MGLL—osteoporosis	0.000681	0.00651	CbGpPWpGaD
Hydroxyurea—Nausea—Zoledronate—osteoporosis	0.00068	0.000776	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ATIC—osteoporosis	0.000677	0.00647	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PNP—osteoporosis	0.000677	0.00647	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PSMA2—osteoporosis	0.000676	0.00646	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PSMA5—osteoporosis	0.000676	0.00646	CbGpPWpGaD
Hydroxyurea—Nausea—Conjugated Estrogens—osteoporosis	0.000655	0.000747	CcSEcCtD
Hydroxyurea—Hypersensitivity—Estradiol—osteoporosis	0.00065	0.000742	CcSEcCtD
Hydroxyurea—Asthenia—Estradiol—osteoporosis	0.000633	0.000722	CcSEcCtD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000609	0.00583	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Estradiol—osteoporosis	0.000604	0.000689	CcSEcCtD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000601	0.00575	CbGpPWpGaD
Hydroxyurea—Dizziness—Estradiol—osteoporosis	0.000583	0.000666	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000581	0.00555	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—IDH2—osteoporosis	0.000579	0.00554	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CA2—osteoporosis	0.000576	0.0055	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—OXCT1—osteoporosis	0.000576	0.0055	CbGpPWpGaD
Hydroxyurea—Vomiting—Estradiol—osteoporosis	0.000561	0.00064	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—MGLL—osteoporosis	0.000561	0.00536	CbGpPWpGaD
Hydroxyurea—Rash—Estradiol—osteoporosis	0.000556	0.000635	CcSEcCtD
Hydroxyurea—Dermatitis—Estradiol—osteoporosis	0.000556	0.000634	CcSEcCtD
Hydroxyurea—Headache—Estradiol—osteoporosis	0.000553	0.000631	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP27A1—osteoporosis	0.000545	0.00521	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000534	0.00511	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000533	0.0051	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ACP5—osteoporosis	0.00053	0.00507	CbGpPWpGaD
Hydroxyurea—Nausea—Estradiol—osteoporosis	0.000524	0.000598	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	0.0005	0.00478	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000498	0.00476	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000494	0.00472	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	0.000493	0.00471	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—TPI1—osteoporosis	0.000492	0.00471	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—IDH2—osteoporosis	0.000477	0.00456	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—P4HB—osteoporosis	0.000463	0.00443	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GAPDH—osteoporosis	0.000454	0.00435	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP27A1—osteoporosis	0.000448	0.00429	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—RAP1A—osteoporosis	0.000443	0.00423	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ACP5—osteoporosis	0.000436	0.00417	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—TPI1—osteoporosis	0.000406	0.00388	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—P4HB—osteoporosis	0.000381	0.00365	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GAPDH—osteoporosis	0.000374	0.00358	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000366	0.0035	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—RAP1A—osteoporosis	0.000365	0.00349	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ENO1—osteoporosis	0.000358	0.00342	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PSMA2—osteoporosis	0.000353	0.00337	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PSMA5—osteoporosis	0.000353	0.00337	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000297	0.00284	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ENO1—osteoporosis	0.000295	0.00282	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PSMA2—osteoporosis	0.00029	0.00278	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PSMA5—osteoporosis	0.00029	0.00278	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP19A1—osteoporosis	0.000286	0.00274	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	0.000262	0.00251	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	0.000259	0.00247	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP19A1—osteoporosis	0.000236	0.00225	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ADCY5—osteoporosis	0.000234	0.00223	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GPX1—osteoporosis	0.000233	0.00223	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—MTHFR—osteoporosis	0.000215	0.00206	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—osteoporosis	0.000213	0.00204	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ADCY5—osteoporosis	0.000192	0.00184	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GPX1—osteoporosis	0.000192	0.00183	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MYC—osteoporosis	0.00019	0.00182	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—MTHFR—osteoporosis	0.000177	0.00169	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—POMC—osteoporosis	0.000172	0.00164	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—POMC—osteoporosis	0.000158	0.00151	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—FDPS—osteoporosis	0.000149	0.00142	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PKM—osteoporosis	0.000149	0.00142	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—POMC—osteoporosis	0.000142	0.00135	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PGLS—osteoporosis	0.000141	0.00135	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GPD2—osteoporosis	0.000141	0.00135	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ATIC—osteoporosis	0.000129	0.00123	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PNP—osteoporosis	0.000129	0.00123	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—OXCT1—osteoporosis	0.00011	0.00105	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CA2—osteoporosis	0.00011	0.00105	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MGLL—osteoporosis	0.000107	0.00102	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—IDH2—osteoporosis	9.09e-05	0.000869	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP27A1—osteoporosis	8.54e-05	0.000817	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ACP5—osteoporosis	8.31e-05	0.000795	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TPI1—osteoporosis	7.73e-05	0.000739	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—P4HB—osteoporosis	7.26e-05	0.000695	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GAPDH—osteoporosis	7.13e-05	0.000682	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—RAP1A—osteoporosis	6.94e-05	0.000664	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ENO1—osteoporosis	5.61e-05	0.000537	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PSMA2—osteoporosis	5.53e-05	0.000529	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PSMA5—osteoporosis	5.53e-05	0.000529	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP19A1—osteoporosis	4.49e-05	0.000429	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ADCY5—osteoporosis	3.67e-05	0.000351	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GPX1—osteoporosis	3.65e-05	0.000349	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MTHFR—osteoporosis	3.37e-05	0.000322	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—POMC—osteoporosis	2.7e-05	0.000258	CbGpPWpGaD
